The Role Of P2X Receptors In Bone Biology.
Jorgensen NR et al. Curr Med Chem. 2014 Dec 14. [Epub ahead of print].
A joined role of canopy and reversal cells in bone remodeling – Lessons from glucocorticoid-induced osteoporosis.
Jensen PR et al. Bone. 2014 Dec 10. pii: S8756-3282(14)00456-6. doi: 10.1016/j.bone.2014.12.004. [Epub ahead of print].
Multiple myeloma and chronic leukaemias in 2014: Improved understanding of disease biology and treatment.
San-Miguel JF et al. Nat Rev Clin Oncol. 2014 Dec 16. doi: 10.1038/nrclinonc.2014.216. [Epub ahead of print].
Are low ultraviolet B and vitamin D associated with higher incidence of multiple myeloma?
Mohr SB et al. J Steroid Biochem Mol Biol. 2014 Dec 10. pii: S0960-0760(14)00311-2. doi: 10.1016/j.jsbmb.2014.12.005. [Epub ahead of print].
‘Management multiple myeloma during pregnancy: a case report and review’
Cabañas-Perianes V et al. Hematol Oncol. 2014 Dec 10. doi: 10.1002/hon.2184. [Epub ahead of print].
Venous thromboembolism in cancer patients.
Deng A et al. Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156.
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.
van der Poel MW et al. Ann Hematol. 2014 Dec 5. [Epub ahead of print].
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center study.
Bhatnagar V et al. Cancer. 2014 Dec 2. doi: 10.1002/cncr.29160. [Epub ahead of print].
Emergence of cancer stem cells or tumor-initiating/propagating cells and relapse in multiple myeloma.
Cahu J et al. Bull Cancer. 2014 Dec 3. [Epub ahead of print].
Multiple Myeloma.
Holstein SA et al. Hematol Oncol Clin North Am. 2014 Dec;28(6):1113-1129. doi: 10.1016/j.hoc.2014.08.010. Epub 2014 Sep 30.
Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.
Martino M et al. Expert Opin Biol Ther. 2014 Nov 29:1-6. [Epub ahead of print].
Controversies in multiple myeloma: to transplant or not?
Preeshagul IR et al. Curr Hematol Malig Rep. 2014 Dec;9(4):360-7. doi: 10.1007/s11899-014-0230-5.
What We Mean When We Talk About MRD in Myeloma. A Review of Current Methods. Part 1 of a Two-Part Series.
Ely S et al. Curr Hematol Malig Rep. 2014 Dec;9(4):379-88. doi: 10.1007/s11899-014-0238-x.
Controversies in the assessment of minimal residual disease in multiple myeloma: clinical significance of minimal residual disease negativity using highly sensitive techniques.
Biran N et al. Curr Hematol Malig Rep. 2014 Dec;9(4):368-78. doi: 10.1007/s11899-014-0237-y.